Search
Close this search box.

Randy Teel named CBO at Arvinas

ARTICLE | Management Tracks

Plus: Meenu Chhabra Karson becomes chair at Harness, and an update from Ontada

By Richard Guy, Biopharma Analyst, and Gunjan Ohri, Data Content Analyst 

April 25, 2024 11:45 PM UTC

Arvinas Inc. (NASDAQ:ARVN) named Randy Teel CBO, a newly created role at the targeted protein degradation company. Teel joined Arvinas in 2018 as VP of corporate development before becoming SVP in 2021. He will also remain interim CFO while the company searches for a permanent successor.

Meenu Chhabra Karson became chair at  Harness Therapeutics Ltd., a neurodegenerative disease company. Chhabra Karson is executive chair at Samsara Therapeutics Inc. and was chair at Apexigen Inc. until 2023…